Total Payments
$4,448
2024 Payments
$95.43
Companies
17
Transactions
274
Medicare Patients
5,073
Medicare Billing
$278,203
Payment Breakdown by Category
Food & Beverage$4,323 (97.2%)
Education$124.94 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,323 | 272 | 97.2% |
| Education | $124.94 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,392 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $802.90 | 71 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $723.98 | 55 | $0 (2023) |
| Lilly USA, LLC | $220.32 | 12 | $0 (2023) |
| UCB, Inc. | $202.45 | 19 | $0 (2024) |
| PFIZER INC. | $187.36 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $171.27 | 5 | $0 (2024) |
| Incyte Corporation | $159.03 | 3 | $0 (2022) |
| Amgen Inc. | $138.25 | 6 | $0 (2023) |
| GENZYME CORPORATION | $124.48 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95.43 | 4 | Regeneron Healthcare Solutions, Inc. ($30.06) |
| 2023 | $929.74 | 48 | ABBVIE INC. ($277.03) |
| 2022 | $1,443 | 80 | ABBVIE INC. ($505.02) |
| 2021 | $1,979 | 142 | AbbVie Inc. ($587.41) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Immunology | ||||||
| 04/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Immunology | ||||||
| 09/13/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Immunology | ||||||
| 09/08/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Dermatology | ||||||
| 09/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Immunology | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Dermatology | ||||||
| 08/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Inflammation | ||||||
| 08/14/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Dermatology | ||||||
| 08/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Immunology | ||||||
| 08/14/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: Dermatology | ||||||
| 08/09/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Dermatology | ||||||
| 08/01/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Dermatology | ||||||
| 07/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Immunology | ||||||
| 07/17/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Immunology | ||||||
| 07/10/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Immunology | ||||||
| 07/06/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: Dermatology | ||||||
| 06/30/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $109.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/19/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Immunology | ||||||
| 06/08/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Biosimilars | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 784 | 1,071 | $193,034 | $38,999 |
| 2022 | 17 | 1,334 | 1,859 | $351,196 | $74,355 |
| 2021 | 17 | 1,437 | 2,029 | $374,115 | $84,468 |
| 2020 | 16 | 1,518 | 2,174 | $379,270 | $80,382 |
Total Patients
5,073
Total Services
7,133
Medicare Billing
$278,203
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 114 | $37,620 | $8,273 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 160 | $36,800 | $7,859 | 21.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 104 | 120 | $34,859 | $7,735 | 22.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 92 | 94 | $25,010 | $4,646 | 18.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 116 | 128 | $21,550 | $3,308 | 15.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $12,825 | $2,040 | 15.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 48 | $6,960 | $1,434 | 20.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 78 | 287 | $4,756 | $1,211 | 25.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 15 | $4,998 | $1,114 | 22.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 25 | 33 | $4,462 | $1,078 | 24.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,775 | $250.25 | 9.0% |
| 87220 | Tissue fungi or parasites | Office | 2023 | 11 | 12 | $420.00 | $50.17 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 241 | 298 | $68,540 | $14,208 | 20.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 164 | 207 | $60,131 | $13,794 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 126 | $41,580 | $9,508 | 22.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 149 | 154 | $40,973 | $7,962 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 124 | 124 | $35,340 | $7,053 | 20.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 164 | 198 | $33,335 | $5,799 | 17.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 94 | 104 | $15,080 | $3,537 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $9,775 | $2,183 | 22.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 101 | 429 | $7,109 | $1,838 | 25.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 45 | 45 | $8,325 | $1,815 | 21.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 41 | 55 | $7,437 | $1,668 | 22.4% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 12 | 14 | $5,630 | $1,370 | 24.3% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 11 | 13 | $4,423 | $1,148 | 26.0% |
About Sandra Hadenfeld, ARNP, MN, FNP-C
Sandra Hadenfeld, ARNP, MN, FNP-C is a Nurse Practitioner healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710123054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Hadenfeld, ARNP, MN, FNP-C has received a total of $4,448 in payments from pharmaceutical and medical device companies, with $95.43 received in 2024. These payments were reported across 274 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,323).
As a Medicare-enrolled provider, Hadenfeld has provided services to 5,073 Medicare beneficiaries, totaling 7,133 services with total Medicare billing of $278,203. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Salem, OR
- Active Since 12/16/2008
- Last Updated 08/06/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1710123054
Products in Payments
- SKYRIZI (Biological) $1,038
- TREMFYA (Drug) $682.47
- COSENTYX (Biological) $529.02
- RINVOQ (Biological) $267.12
- DUPIXENT (Biological) $259.61
- TALTZ (Drug) $220.32
- REMICADE (Biological) $196.40
- COSENTYX (Drug) $183.32
- Cimzia (Drug) $181.58
- EUCRISA (Drug) $143.66
- Otezla (Drug) $114.10
- Sotyktu (Drug) $66.41
- HUMIRA (Biological) $58.48
- OPZELURA (Drug) $46.41
- SIMPONI ARIA (Biological) $44.63
- CIBINQO (Drug) $43.70
- ENSTILAR (Drug) $39.29
- AMELUZ (Drug) $27.16
- IDACIO (Biological) $26.90
- Enbrel (Biological) $24.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Salem
Deborah Geary, Np, NP
Nurse Practitioner — Payments: $74,244
Nurse Practitioner $74,244
Mrs. Jillian Oppenheim, Aprn Bc Fnp, APRN BC FNP
Nurse Practitioner — Payments: $9,258
Nurse Practitioner $9,258
Brian Fellows, Np, NP
Nurse Practitioner — Payments: $7,017
Nurse Practitioner $7,017
Lorraine Cresanto, Crnp, CRNP
Nurse Practitioner — Payments: $5,237
Nurse Practitioner $5,237
Lauren Williams, Fnp, FNP
Nurse Practitioner — Payments: $4,582
Nurse Practitioner $4,582
Margaret Ross, Arnp, ARNP
Nurse Practitioner — Payments: $4,244
Nurse Practitioner $4,244